Berberine and Its Study as an Antidiabetic Compound
Biology · 08.07.2023 · 12 (7) · 973
DOI: 10.3390/biology12070973 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 08.07.2023. Verfasst von Ayudiah Rizki Utami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Padjadjaran University, Riset Data Pustaka dan Daring (RDPD) 2023.
Abstract (Originalsprache)
Diabetes mellitus (DM) is a metabolic disorder that causes hyperglycemia conditions and leads to various chronic complications that causes death. The prevalence of diabetes is predicted to continue to increase, and with the high toxicity levels of current diabetes drugs, the exploration of natural compounds as alternative diabetes treatment has been widely carried out, one of which is berberine. Berberine and several other alkaloid compounds, including some of its derivatives, have shown many bioactivities, such as neuraminidase and hepatoprotective activity. Berberine also exhibits antidiabetic activity. As an antidiabetic compound, berberine is known to reduce blood glucose levels, increase insulin secretion, and weaken glucose tolerance and insulin resistance by activating the AMPK pathway. Apart from being an antidiabetic compound, berberine also exhibits various other activities such as being anti-adipogenic, anti-hyperlipidemic, anti-inflammatory, and antioxidant. Many studies have been conducted on berberine, but its exact mechanism still needs to be clarified and requires further investigation. This review will discuss berberine and its mechanism as a natural compound with various activities, mainly as an antidiabetic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang 45363, Indonesia.
ORCID-Profile: Yusi Deawati
Förderung
- Padjadjaran University
- Riset Data Pustaka dan Daring (RDPD) 2023
Zitieren
APA
Utami, A. R., Maksum, I. P., & Deawati, Y. (2023). Berberine and Its Study as an Antidiabetic Compound. Biology, 12(7), 973. https://doi.org/10.3390/biology12070973
Vancouver
Utami AR, Maksum IP, Deawati Y. Berberine and Its Study as an Antidiabetic Compound. Biology. 2023;12(7):973. doi:10.3390/biology12070973
BibTeX
@article{Utami2023,
author = {Utami, Ayudiah Rizki and Maksum, Iman Permana and Deawati, Yusi},
title = {Berberine and Its Study as an Antidiabetic Compound},
journal = {Biology},
year = {2023},
volume = {12},
number = {7},
pages = {973},
doi = {10.3390/biology12070973}
}
EUVIMED